Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Flaig

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Allergy and Clinical Immunology|April 25, 2006
Cathelicidin deficiency predisposes to eczema herpeticumMichael D Howell, Andreas Wollenberg, Richard L Gallo, et al.
Biomed Research International|April 14, 2015
Patients with intolerance reactions to total knee replacement: combined assessment of allergy diagnostics, periprosthetic histology, and peri-implant cytokine expression patternPeter Thomas, Christine von der Helm, Christoph Schopf, et al.
Cancers|January 11, 2025
Benign or Malignant? Ex Vivo Confocal Laser Scanning Microscopy for Bedside Histological Assessment of Melanocytic LesionsMaximilian Deußing, Lisa Buttgereit, Michaela Maurer, et al.
Molecular & Cellular Proteomics : MCP|July 4, 2002
2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markersGe Zhou, Hongmei Li, Dianne DeCamp, et al.
Clinical and Translational Medicine|January 15, 2025
RECQL4 affects MHC class II-mediated signalling and favours an immune-evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanomaSara Egea-Rodriguez, Renáta Váraljai, Thierry M Nordmann, et al.
EMBO Molecular Medicine|May 14, 2013
The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survivalTobias Hohenauer, Carola Berking, Andreas Schmidt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 17, 2023
S2k Guideline - Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - Update 2022Jürgen C Becker, Ambros J Beer, Viola K DeTemple, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 5, 2020
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicatorsMarkus V Heppt, Ulrike Leiter, Theresa Steeb, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 5, 2020
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational diseaseUlrike Leiter, Markus V Heppt, Theresa Steeb, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Allergy and Clinical Immunology|April 25, 2006
Cathelicidin deficiency predisposes to eczema herpeticumMichael D Howell, Andreas Wollenberg, Richard L Gallo, et al.
Biomed Research International|April 14, 2015
Patients with intolerance reactions to total knee replacement: combined assessment of allergy diagnostics, periprosthetic histology, and peri-implant cytokine expression patternPeter Thomas, Christine von der Helm, Christoph Schopf, et al.
Cancers|January 11, 2025
Benign or Malignant? Ex Vivo Confocal Laser Scanning Microscopy for Bedside Histological Assessment of Melanocytic LesionsMaximilian Deußing, Lisa Buttgereit, Michaela Maurer, et al.
Molecular & Cellular Proteomics : MCP|July 4, 2002
2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markersGe Zhou, Hongmei Li, Dianne DeCamp, et al.
Clinical and Translational Medicine|January 15, 2025
RECQL4 affects MHC class II-mediated signalling and favours an immune-evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanomaSara Egea-Rodriguez, Renáta Váraljai, Thierry M Nordmann, et al.
EMBO Molecular Medicine|May 14, 2013
The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survivalTobias Hohenauer, Carola Berking, Andreas Schmidt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 17, 2023
S2k Guideline - Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - Update 2022Jürgen C Becker, Ambros J Beer, Viola K DeTemple, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 5, 2020
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicatorsMarkus V Heppt, Ulrike Leiter, Theresa Steeb, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 5, 2020
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational diseaseUlrike Leiter, Markus V Heppt, Theresa Steeb, et al.
Pageof 2